we have started to provide the documents for our products in an electronic format. These are the Instructions for Use (IFU), the Safety Data Sheets (SDS) and the Certificate of Analysis (CoA). For batches placed on the market after 01 January 2023, you can find our documents on the eIFU portal https://eifu.r-biopharm.com.
Etwa 50 % der Typ-1-Diabetiker, 33 % der Typ-2-Diabetiker und 75 – 80 % der Mukoviszidosepatienten entwickeln im Laufe ihrer Erkrankung eine exokrine Pankreasinsuffizienz. (Hardt PD, [...]
